| 2026 |
| 10/01 | 1,315 | 1,324 | 1,306 | 1,306 | -1.36% | 63,000 | - | -0.84% |
| 09/30 | (IR情報)15:30 ダイト、Meiji Seikaファルマ及び日本政策投資銀行が設立する共同出資会社による杏林製薬の後発医薬品事業の承継に関する合弁契約及び株式譲渡契約の締結 |
| 09/30 | 1,309 | 1,332 | 1,291 | 1,324 | +0.68% | 67,000 | - | +0.38% |
| 09/29 | 1,344 | 1,348 | 1,315 | 1,315 | -2.59% | 62,000 | - | -0.38% |
| 09/28 | 1,343 | 1,357 | 1,343 | 1,350 | 0% | 62,300 | - | +2.12% |
| 09/25 | 1,346 | 1,360 | 1,338 | 1,350 | 0% | 108,800 | - | +2.2% |
| 09/24 | 1,341 | 1,351 | 1,337 | 1,350 | +1.28% | 80,600 | - | +2.2% |
| 09/18 | 1,314 | 1,338 | 1,314 | 1,333 | +0.53% | 105,600 | - | +1.06% |
| 09/17 | 1,285 | 1,326 | 1,285 | 1,326 | +3.03% | 54,900 | - | +0.53% |
| 09/16 | 1,289 | 1,302 | 1,286 | 1,287 | -0.16% | 61,800 | - | -2.28% |
| 09/15 | 1,256 | 1,292 | 1,256 | 1,289 | +1.34% | 50,800 | - | -2.13% |
| 09/14 | 1,258 | 1,272 | 1,253 | 1,272 | +1.52% | 65,200 | - | -3.34% |
| 09/11 | 1,260 | 1,260 | 1,236 | 1,253 | -1.57% | 85,700 | - | -4.86% |
| 09/10 | 1,240 | 1,273 | 1,238 | 1,273 | +0.63% | 83,300 | - | -3.27% |
| 09/09 | 1,270 | 1,272 | 1,260 | 1,265 | -0.55% | 74,500 | - | -3.73% |
| 09/08 | 1,266 | 1,285 | 1,260 | 1,272 | -1.24% | 73,000 | - | -3.12% |
| 09/07 | 1,299 | 1,303 | 1,279 | 1,288 | -1.3% | 40,300 | - | -1.75% |
| 09/04 | 1,308 | 1,314 | 1,300 | 1,305 | -0.68% | 105,900 | - | -0.38% |
| 09/03 | 1,323 | 1,329 | 1,303 | 1,314 | -0.68% | 79,200 | - | +0.38% |
| 09/02 | 1,319 | 1,335 | 1,316 | 1,323 | +0.15% | 84,300 | - | +1.15% |
| 09/01 | 1,324 | 1,340 | 1,316 | 1,321 | -0.9% | 103,600 | - | +1.15% |
| 08/31 | 1,323 | 1,340 | 1,322 | 1,333 | -1.33% | 77,100 | - | +2.15% |
| 08/28 | 1,365 | 1,377 | 1,351 | 1,351 | -2.1% | 62,400 | - | +3.68% |
| 08/27 | 1,375 | 1,385 | 1,361 | 1,380 | +0.36% | 59,000 | - | +6.15% |
| 08/26 | 1,361 | 1,378 | 1,361 | 1,375 | +1.03% | 48,700 | - | +6.1% |
| 08/25 | 1,360 | 1,371 | 1,359 | 1,361 | +0.07% | 36,400 | - | +5.34% |
| 08/24 | 1,358 | 1,384 | 1,351 | 1,360 | -0.22% | 66,400 | - | +5.43% |
| 08/21 | 1,358 | 1,373 | 1,349 | 1,363 | +0.44% | 63,100 | - | +5.82% |
| 08/20 | 1,329 | 1,360 | 1,329 | 1,357 | +1.72% | 91,000 | - | +5.52% |
| 08/19 | 1,345 | 1,345 | 1,325 | 1,334 | -0.07% | 45,800 | - | +3.81% |
| 08/18 | 1,316 | 1,342 | 1,316 | 1,335 | +1.44% | 41,600 | - | +4.05% |
| 08/17 | 1,315 | 1,327 | 1,314 | 1,316 | -0.15% | 58,500 | - | +2.81% |
| 08/17 | (空売り報告)Nomura International plc 140,441株(0.48%)-0.11%義務消失 |
| 08/14 | 1,289 | 1,322 | 1,289 | 1,318 | +2.25% | 56,500 | - | +3.21% |
| 08/13 | 1,275 | 1,294 | 1,273 | 1,289 | +1.1% | 50,500 | - | +1.18% |
| 08/12 | 1,290 | 1,290 | 1,265 | 1,275 | -0.08% | 81,700 | - | +0.24% |
| 08/12 | (空売り報告)Nomura International plc 173,067株(0.59%)-0.02% |
| 08/10 | 1,275 | 1,279 | 1,262 | 1,276 | 0% | 62,900 | - | +0.39% |
| 08/07 | 1,235 | 1,277 | 1,235 | 1,276 | +2.74% | 75,300 | - | +0.47% |
| 08/06 | (自社株買い)取締役会(2026年7月10日)での決議状況(取得期間2026年7月13日~2026年7月13日) |
| 08/06 | 1,231 | 1,244 | 1,228 | 1,242 | +0.98% | 67,600 | - | -2.05% |
| 08/05 | 1,233 | 1,243 | 1,228 | 1,230 | +0.65% | 36,700 | - | -2.92% |
| 08/04 | 1,233 | 1,243 | 1,222 | 1,222 | -1.45% | 72,900 | - | -3.55% |
| 08/03 | 1,254 | 1,254 | 1,233 | 1,240 | -1.04% | 106,900 | - | -2.21% |
| 07/31 | 1,271 | 1,276 | 1,253 | 1,253 | -2.11% | 61,300 | - | -1.18% |
| 07/30 | 1,288 | 1,298 | 1,263 | 1,280 | -1.01% | 81,700 | - | +1.03% |
| 07/30 | (空売り報告)Nomura International plc 177,165株(0.61%)+0.07% |
| 07/29 | 1,275 | 1,302 | 1,255 | 1,293 | +1.41% | 72,200 | - | +2.21% |
| 07/28 | 1,307 | 1,307 | 1,270 | 1,275 | -2% | 70,500 | - | +1.03% |
| 07/27 | 1,279 | 1,303 | 1,279 | 1,301 | +2.12% | 60,100 | - | +3.34% |
| 07/24 | 1,276 | 1,286 | 1,268 | 1,274 | -0.16% | 43,300 | - | +1.51% |
| 07/23 | 1,271 | 1,286 | 1,256 | 1,276 | +0.39% | 50,000 | - | +1.92% |
| 07/22 | 1,276 | 1,279 | 1,264 | 1,271 | -1.78% | 57,300 | - | +1.68% |
| 07/21 | 1,325 | 1,329 | 1,286 | 1,294 | -1.15% | 47,200 | - | +3.77% |
| 07/17 | 1,305 | 1,323 | 1,295 | 1,309 | +0.69% | 60,400 | - | +5.23% |
| 07/16 | 1,295 | 1,323 | 1,295 | 1,300 | -0.99% | 57,100 | - | +4.84% |
| 07/15 | (IR情報)17:00 2026年5月期決算説明資料 |
| 07/15 | 1,331 | 1,336 | 1,300 | 1,313 | -1.2% | 103,400 | - | +6.23% |
| 07/14 | 1,292 | 1,341 | 1,292 | 1,329 | +2.7% | 131,600 | - | +7.96% |
| 07/14 | (空売り報告)Nomura International plc 157,964株(0.54%)-0.09% |
| 07/13 | (IR情報)11:00 自己株式立会外買付取引(ToSTNeT-3)による自己株式の取得結果及び自己株式の取得終了に関するお知らせ |
| 07/13 | 1,254 | 1,340 | 1,254 | 1,294 | +3.52% | 329,800 | - | +5.63% |
| 07/13 | (空売り報告)Barclays Capital Securities Ltd 123,908株(0.42%)-0.12%義務消失 |
| 07/10 | (IR情報)16:30 自己株式の取得及び自己株式立会外買付取引(ToSTNeT-3)による自己株式の買付けに関するお知らせ |
| 07/10 | (IR情報)16:30 代表取締役の異動及び新任取締役候補者の選任ならびに執行役員の異動に関するお知らせ |
| 07/10 | (IR情報)16:30 2026年5月期決算短信〔日本基準〕(連結) |
| 07/10 | (IR情報)16:30 組織再編に関するお知らせ |
| 07/10 | 1,252 | 1,269 | 1,242 | 1,250 | +0.24% | 102,700 | - | +2.46% |
| 07/09 | 1,268 | 1,268 | 1,243 | 1,247 | -0.16% | 93,200 | - | +2.55% |
| 07/08 | 1,247 | 1,256 | 1,233 | 1,249 | +0.81% | 52,300 | - | +3.14% |
| 07/07 | 1,234 | 1,250 | 1,234 | 1,239 | -0.08% | 28,300 | - | +2.65% |
| 07/06 | 1,259 | 1,275 | 1,240 | 1,240 | -0.48% | 51,900 | - | +3.08% |
| 07/03 | 1,255 | 1,262 | 1,245 | 1,246 | +0.4% | 54,600 | - | +3.83% |
| 07/02 | 1,229 | 1,249 | 1,222 | 1,241 | +1.8% | 75,700 | - | +3.59% |
| 07/01 | 1,215 | 1,225 | 1,211 | 1,219 | -1.06% | 48,900 | - | +1.92% |
| 06/30 | 1,236 | 1,244 | 1,226 | 1,232 | -0.96% | 87,800 | - | +3.01% |
| 06/29 | 1,254 | 1,254 | 1,231 | 1,244 | +1.63% | 111,600 | - | +4.01% |
| 06/29 | (空売り報告)Nomura International plc 182,677株(0.63%)-0.07% |
| 06/26 | 1,241 | 1,242 | 1,221 | 1,224 | -1.37% | 46,900 | - | +2.43% |
| 06/25 | 1,217 | 1,247 | 1,213 | 1,241 | +1.97% | 71,500 | - | +3.85% |
| 06/24 | 1,229 | 1,255 | 1,214 | 1,217 | -1.3% | 71,700 | - | +1.93% |
| 06/24 | (空売り報告)Nomura International plc 202,817株(0.7%)+0.01% |
| 06/23 | (IR情報)15:30 ダイトグループ 中国における6例目の自社ジェネリック製剤の承認取得 |
| 06/23 | 1,199 | 1,234 | 1,199 | 1,233 | +2.84% | 80,400 | - | +3.09% |
| 06/23 | (空売り報告)Nomura International plc 201,088株(0.69%)-0.07% |
| 06/22 | 1,197 | 1,215 | 1,195 | 1,199 | +1.01% | 69,900 | - | +0.17% |
| 06/19 | 1,213 | 1,231 | 1,172 | 1,187 | -2.3% | 149,500 | - | -0.92% |
| 06/18 | 1,212 | 1,221 | 1,202 | 1,215 | +0.25% | 47,600 | - | +1.25% |
| 06/17 | 1,218 | 1,232 | 1,212 | 1,212 | +0.25% | 79,400 | - | +0.92% |
| 06/16 | 1,200 | 1,217 | 1,198 | 1,209 | +0.17% | 62,700 | - | +0.67% |
| 06/15 | 1,221 | 1,237 | 1,205 | 1,207 | -0.17% | 94,100 | - | +0.42% |
| 06/12 | (IR情報)15:30 医療用医薬品新発売のお知らせ |
| 06/12 | 1,203 | 1,220 | 1,195 | 1,209 | +0.5% | 94,800 | - | +0.5% |
| 06/11 | (自社株買い)取締役会(2025年10月10日)での決議状況(取得期間2025年10月15日~2026年5月22日) |
| 06/11 | 1,198 | 1,215 | 1,187 | 1,203 | +0.75% | 101,200 | - | 0% |
| 06/10 | 1,180 | 1,200 | 1,171 | 1,194 | +1.02% | 104,900 | - | -0.91% |
| 06/09 | 1,159 | 1,182 | 1,154 | 1,182 | +2.16% | 100,100 | - | -2.07% |
| 06/08 | 1,137 | 1,161 | 1,137 | 1,157 | +0.26% | 103,600 | - | -4.38% |
| 06/05 | 1,140 | 1,159 | 1,136 | 1,154 | +2.03% | 119,400 | - | -4.94% |
| 06/04 | 1,125 | 1,138 | 1,120 | 1,131 | -0.62% | 67,000 | - | -7.22% |
| 06/03 | 1,140 | 1,141 | 1,122 | 1,138 | -0.18% | 117,400 | - | -7.1% |
| 06/02 | 1,145 | 1,151 | 1,127 | 1,140 | -1.98% | 91,800 | - | -7.47% |
| 06/02 | (空売り報告)Barclays Capital Securities Ltd 163,508株(0.54%)再IN |
| 06/01 | (IR情報)15:30 自己株式の消却完了に関するお知らせ |
| 06/01 | 1,199 | 1,199 | 1,148 | 1,163 | -3.24% | 127,100 | - | -6.13% |
| 05/29 | 1,195 | 1,217 | 1,195 | 1,202 | +0.42% | 56,600 | - | -3.45% |
| 05/28 | 1,207 | 1,207 | 1,197 | 1,197 | -1.8% | 101,100 | - | -4.32% |
| 05/27 | 1,208 | 1,222 | 1,208 | 1,219 | +0.41% | 153,000 | - | -3.02% |
| 05/27 | (空売り報告)Nomura International plc 230,116株(0.76%)-0.06% |
| 05/26 | 1,214 | 1,217 | 1,208 | 1,214 | -0.16% | 85,800 | - | -3.88% |
| 05/25 | 1,229 | 1,230 | 1,210 | 1,216 | -0.73% | 68,500 | - | -4.18% |
| 05/22 | 1,237 | 1,237 | 1,220 | 1,225 | -0.89% | 51,100 | - | -3.92% |
| 05/21 | 1,260 | 1,262 | 1,235 | 1,236 | -1.28% | 37,500 | - | -3.51% |
| 05/20 | (IR情報)15:30 取締役の異動に関するお知らせ |
| 05/20 | 1,260 | 1,281 | 1,242 | 1,252 | -0.79% | 89,800 | - | -2.8% |
| 05/19 | 1,225 | 1,266 | 1,225 | 1,262 | +3.44% | 120,100 | - | -2.55% |
| 05/18 | 1,245 | 1,245 | 1,218 | 1,220 | -2.01% | 77,700 | - | -6.3% |
| 05/15 | 1,225 | 1,248 | 1,225 | 1,245 | +0.89% | 72,500 | - | -5.03% |
| 05/14 | 1,234 | 1,239 | 1,222 | 1,234 | +0.82% | 66,600 | - | -6.44% |
| 05/13 | (IR情報)15:30 「オパルモン錠」及び「プロスタンディン軟膏」の日本における販売提携契約を科研製薬と締結 |
| 05/13 | 1,232 | 1,232 | 1,220 | 1,224 | -0.33% | 60,700 | - | -7.76% |
| 05/12 | (自社株買い)取締役会(2025年10月10日)での決議状況(取得期間2025年10月15日~2026年5月22日) |
| 05/12 | 1,240 | 1,243 | 1,220 | 1,228 | +0.57% | 67,800 | - | -8.08% |
| 05/11 | 1,231 | 1,239 | 1,219 | 1,221 | -0.33% | 74,500 | - | -9.29% |
| 05/11 | (空売り報告)Barclays Capital Securities Ltd 95,608株(0.31%)-0.2%義務消失 |
| 05/08 | 1,244 | 1,244 | 1,225 | 1,225 | -1.53% | 86,200 | - | -9.59% |
| 05/07 | (空売り報告)Nomura International plc 246,936株(0.82%)+0.05% |